Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Monsanto Roundup Recall from Store Shelves in Europe May Be Issued If License Not Renewed This Month June 7, 2016 Irvin Jackson Add Your Comments Monsanto faces the real possibility of being forced to recall Roundup from store shelves in Europe, after a proposal to give the weed killer glyphosate a limited license extension failed to garner enough votes from European Union member states. On Monday, member states of the EU voted 20 to 7 to grant a 12 to 18 month extension on the license for the use of glyphosate, the active ingredient in Monsanto’s popular Roundup weedkiller. However, under EU rules, a vote must represent 65% of the EU’s population for a proposal to go forward, which this most recent vote failed to achieve. The vote comes as Monsanto faces a June 30 deadline, when its license for glyphosate will expire. If that deadline is reached, all glyphosate products must be removed from stores in the European Union. ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The problems stem from mounting concerns over the potential health risks associated with Roundup exposure, after the World Health Organization’s International Agency for Research on Cancer (IARC) declared that glyphosate is likely a cancer-causing agent last year. The warning has sparked debate worldwide about the potential link between Roundup and non-Hodgkins lymphoma, as well as other forms of cancer. Monsanto has aggressively criticized the decision to list their Roundup as a human carcinogen, dismissing the IARC findings as agenda driven and based on “junk science.” The European Food Safety Authority (EFSA) has also conflicted with the IARC findings, declaring glyphosate to be safe. Scientists and supporters on both sides of the debate have called the processes of the other unscientific, and the European Commission has delayed the renewal of glyphosate’s license across Europe. Due to objections from several member states, the European executive called for a 12 to 18 month extension on the license to give time for a further study by the European Chemicals Agency (ECHA) into Roundup side effects and potential health risks. The normal license renewal lasts for 15 years. Germany, one of the largest EU members, abstained from the vote as Germany-based Bayer Healthcare has put forward a $62 billion bid to buy Monsanto. Roundup Lawsuits in the U.S. A recent U.S. Geological Survey on glyphosate usage nationwide found that an estimated 2.6 billion pounds of the herbicide has been sprayed on America’s agricultural land over the two decades since the mid-1990s, when Monsanto introduced “Roundup Ready” crops that are designed to survive being sprayed with glyphosate, killing the weeds but not the crops. In all that time, the FDA has never tested for residue or buildup in the food sold to Americans nationwide. In a report published in 2014, the Government Accountability Office (GAO) criticized the FDA for this deficiency in its pesticide program. Monsanto now faces a growing number of Roundup cancer lawsuits in the United States, typically involving individuals diagnosed with a form of non-Hodgkin’s lymphoma following heavy exposure to the herbicide as a farm or agricultural worker. The complaints allege that plaintiffs may have avoided a cancer diagnosis if they had been warned about the Roundup risks for farmers, landscapers and others in the agricultural industry, as safety precautions could have been taken or other products could have been used to control the growth of weeds. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Cancer, Glyphosate, Herbicide, Monsanto, Non-Hodgkins Lymphoma, Roundup Image Credit: Photo Courtesy of <a href="https://www.flickr.com/photos/jeepersmedia/14873964648/in/photolist-oEmXum-oEn9ki-oWRbVK-oEmWnm-oWzFRi-oWPp5q-oEmvVY-oEmahn-oEmb2Z-r4HEKx-qrgbpD-qr3Syo-qrgb6x-r4HT7B-qrg5px-r6sNDC-rnWUhU-rnV1kP-qr3DSm-rnWEWf-qrfS4a-qk19Pd-argEhZ-7xtMSn-ettS6G-qk2CQb-qnhf96-pqi9cy-8CVPxp-pqwwpc-smqxZX-sjb3fb-7xtMYM-q5QsjF-rinfWJ-qndT8S-pqwisv-pqhREq-qndxjo-qn6XWT-q5Hp19-q5JaP9-q5J8Wm-q5HsUG-qngP1k-qn6VRF-fj2VwZ-cnzyy9-seffn5-rV4Khp">Mike Mozart via Flickr</a> Creative Commons More Roundup Lawsuit Stories Roundup Safety Study Retracted Decades After Publication December 8, 2025 Monsanto Roundup Settlement Avoids $2B Payout in Non-Hodgkin’s Lymphoma Lawsuit November 18, 2025 Bayer’s Roundup Lawsuit Payouts Result in Another $1.37B in Reserves August 4, 2025 0 Comments NameThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Bard PowerPort Infection Lawsuit Set for Trial To Begin April 21, 2026 (Posted: today) A federal judge has scheduled a series of Bard PowerPort trials between April 2026 and February 2027, which will focus on allegations that defective design flaws made the devices susceptible to infections, fractures and migration. MORE ABOUT: BARD POWERPORT LAWSUITCook Flexor Sheath Lawsuit Claims Defective Catheter Device Led to Woman’s Death (01/06/2026)More Than 2,500 Bard Powerport Lawsuits Filed in Federal Courts Nationwide (12/05/2025)Six Bard PowerPort Lawsuits Will Go Before Juries Between May 2026 and Feb. 2027 (11/26/2025) Depo-Provera Lawyers Intending To Remain in MDL Leadership Must Seek Reappointment: Judge (Posted: yesterday) A federal judge is calling for dozens of attorneys to reapply for leadership positions in Depo-Provera brain tumor litigation before their appointments expire in March. MORE ABOUT: DEPO-PROVERA LAWSUITSide Effects From Depo-Provera Shots Led to Brain Tumor, Multiple Surgeries: Lawsuit (01/06/2026)Top Medical Device Recalls and Warnings of 2025 Resulting in Lawsuits and Investigations (12/29/2025)Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (12/23/2025) Judge Overseeing Ozempic Blindness Lawsuits Meeting With Lawyers for Initial Conference (Posted: 2 days ago) Parties involved with Ozempic blindness lawsuits will meet with a federal judge overseeing the litigation for the first time on January 13. MORE ABOUT: OZEMPIC LAWSUITFDA To Remove Suicide Risks From GLP-1 Side Effects Warnings (01/15/2026)Link Between Gastroparesis and Ozempic, Other GLP-1 Medications To Be Reviewed by MDL Court in 2026 (12/23/2025)Ozempic, Wegovy Vision Loss Lawsuits Sent to Stomach Injury Judge, as Separate MDL (12/18/2025)
Bard PowerPort Infection Lawsuit Set for Trial To Begin April 21, 2026 (Posted: today) A federal judge has scheduled a series of Bard PowerPort trials between April 2026 and February 2027, which will focus on allegations that defective design flaws made the devices susceptible to infections, fractures and migration. MORE ABOUT: BARD POWERPORT LAWSUITCook Flexor Sheath Lawsuit Claims Defective Catheter Device Led to Woman’s Death (01/06/2026)More Than 2,500 Bard Powerport Lawsuits Filed in Federal Courts Nationwide (12/05/2025)Six Bard PowerPort Lawsuits Will Go Before Juries Between May 2026 and Feb. 2027 (11/26/2025)
Depo-Provera Lawyers Intending To Remain in MDL Leadership Must Seek Reappointment: Judge (Posted: yesterday) A federal judge is calling for dozens of attorneys to reapply for leadership positions in Depo-Provera brain tumor litigation before their appointments expire in March. MORE ABOUT: DEPO-PROVERA LAWSUITSide Effects From Depo-Provera Shots Led to Brain Tumor, Multiple Surgeries: Lawsuit (01/06/2026)Top Medical Device Recalls and Warnings of 2025 Resulting in Lawsuits and Investigations (12/29/2025)Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (12/23/2025)
Judge Overseeing Ozempic Blindness Lawsuits Meeting With Lawyers for Initial Conference (Posted: 2 days ago) Parties involved with Ozempic blindness lawsuits will meet with a federal judge overseeing the litigation for the first time on January 13. MORE ABOUT: OZEMPIC LAWSUITFDA To Remove Suicide Risks From GLP-1 Side Effects Warnings (01/15/2026)Link Between Gastroparesis and Ozempic, Other GLP-1 Medications To Be Reviewed by MDL Court in 2026 (12/23/2025)Ozempic, Wegovy Vision Loss Lawsuits Sent to Stomach Injury Judge, as Separate MDL (12/18/2025)